PERSPECTA

News from every angle

Back to headlines

TD Cowen Reaffirms Buy Rating for Boston Scientific (BSX)

TD Cowen has maintained its 'Buy' rating for Boston Scientific (BSX), indicating continued confidence in the company's stock performance.

25 Jun, 11:58 — 25 Jun, 11:58
PostShare

Sources

Showing 1 of 1 sources